/ Report Details / Drug Device Combination Market

Drug Device Combination Market, By Product (Drug Eluting Stents, Infusion Pumps, Photosensitizers, Orthopedic Combination products, Wound care combination products, Inhalers, and Others), By End-Users (Hospitals & Clinics, Ambulatory Surgery Centers (ASCs), Home Care Settings, and others) and by Region (NA, EU, APAC, LA, MEA) Analysis, Size, Share, Trends, & Forecast from 2021-2027

Report Code: AV1056

Industry: Healthcare

Publiced On: 2021-12-10

Pages: 300

Format: ppt pdf

REPORT HIGHLIGHT

The Drug-Device Combination market is expected to be valued at USD 118.4 billion in 2020, growing with 9.8% CAGR during the forecast period, 2021-2027.

Therapeutic and diagnostic goods that include both a drug and a medical device are known as drug-device combination products. Traditional drug/device combo items include prefilled syringes, drug-coated devices, and co-packages, to name a few.

Market Dynamics

The rise in the incidence of chronic diseases such as diabetes, cancer, and respiratory problems, as well as an increase in casualties due to accidents and trauma, a rise in the geriatric population, growth in the home-based healthcare market, and technological advancements such as the development of prefilled syringes, are driving the growth of the Global Drug-device Combination Products Market. However, the market expansion is hampered by issues such as unforeseen complications of drug-device combination products and severe regulatory regulations. Increased healthcare infrastructure and huge market potential in underdeveloped emerging markets, on the other hand, are projected to benefit the market.

Product Takeaway

Coronary stents and peripheral vascular stents are two types of drug-eluting stents. Implantable infusion pumps, insulin infusion pumps, patient-controlled analgesia pumps, and ambulatory infusion pumps are the different types of infusion pumps. Single-chamber prefilled syringes, dual-chamber prefilled syringes, and customized prefilled syringes are all types of prefilled syringes. The drug-eluting balloon section is divided into two parts: coronary and peripheral drug-eluting balloons. Drug powder inhalers, metered-dose inhalers, and soft mist inhalers are the three types of inhalers.

End-User Takeaway

The market is segmented into hospitals and clinics, ambulatory surgery facilities, home care settings, and another ultimate consumer, depending on the final user. In 2018, the hospital & clinic category had the largest market share, but the ambulatory surgery center segment is predicted to grow at the fastest rate throughout the forecast period.

Regional Takeaway

North America is expected to have a strong position in the global clinical therapy products market over the projected period, owing to the increasing approval and introduction of new pharmaceuticals in the area. For example, the US Food and Drug Administration approved Flowonix Medical, Inc.'s Prometra II Programmable Pump System for use with intrathecal baclofen in February 2020. The Prometra II Pump delivers boluses of medication into the intrathecal space via a pressure-driven, valve-gated delivery mechanism.

COVID-19 Impact

During the forecast period, the worldwide drug-device combination products market is projected to be hampered by the COVID-19 pandemic. The COVID-19 epidemic, as well as the resulting lockdowns in numerous countries throughout the world, has had a financial impact on enterprises of all kinds. The COVID-19 epidemic has had a significant impact on the private healthcare industry. During the epidemic, several clinical experiments were halted.

Key Vendor Takeaway

Some of the major players in this industry include Abbott Laboratories, Stryker Corporation, Medtronic, Allergan, Plc, Novartis AG, C.R. Bard, Inc., W.L.Core & Associates, Inc., Teleflex Incorporated, Boston Scientific Corporation, St.Jude Medical, Inc., Mylan N.V., Terumo Corporation, and Others.

The market size and forecast for each segment and sub-segments has been considered as below:

  • Historical Year – 2016 to 2018
  • Base Year – 2020
  • Projected Year – 2021 to 2027

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DRUG-DEVICE COMBINATION MARKET KEY PLAYERS

  • Abbott Laboratories
  • Allergan Plc.
  • Boston Scientific Corporation
  • R. Bard, Inc
  • Medtronic
  • Mylan N.V
  • Novartis AG
  • Jude Medical Inc.
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • L.Core & Associates, Inc
  • Others

GLOBAL DRUG-DEVICE COMBINATION MARKET, BY PRODUCT

  • Drug-Eluting Stents
  • Infusion Pumps
  • Photosensitizers
  • Orthopedic Combination products
  • Wound care combination products
  • Inhalers
  • Others

GLOBAL DRUG-DEVICE COMBINATION MARKET, BY END-USER

  • Hospitals & Clinics
  • Ambulatory Surgery Centers (ASCs)
  • Home Care Settings
  • Others

GLOBAL DRUG-DEVICE COMBINATION MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Rest of MEA

TABLE OF CONTENT

1. DRUG DEVICE COMBINATION MARKET OVERVIEW
1.1. Study Scope
2. EXECUTIVE SUMMARY
2.1. Market Snippet
2.1.1. Market Snippet by Product
2.1.2. Market Snippet by End-User
2.1.3. Market Snippet by Region
2.2. Competitive Insights
3. DRUG DEVICE COMBINATION KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. DRUG-DEVICE COMBINATION INDUSTRY STUDY
4.1. Porter’s Five Forces Analysis
4.2. Marketing Strategy Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. DRUG DEVICE COMBINATION MARKET: COVID-19 IMPACT ANALYSIS
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. DRUG DEVICE COMBINATION MARKET LANDSCAPE
6.1. Market Share Analysis, 2020
6.2. Key Innovators Analysis
6.3. Breakdown Data, by Key Manufacturer
6.3.1. Established Players’ Analysis
6.3.2. Emerging Players’ Analysis
7. DRUG DEVICE COMBINATION MARKET – BY PRODUCT
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2020 & 2027 (%)
7.2. Wound care combination products
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
7.3. Orthopedic Combination products
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
7.4. Photosensitizers
7.4.1. Overview
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
7.5. Infusion Pumps
7.5.1. Overview
7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
7.6. Drug Eluting Stents
7.6.1. Overview
7.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
7.7. Others
7.7.1. Overview
7.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
8. DRUG DEVICE COMBINATION MARKET – BY END-USER
8.1. Overview
8.1.1. Segment Share Analysis, By Aircraft Type, 2020 & 2027 (%)
8.2. Hospitals & Clinics
8.2.1. Overview
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
8.3. Ambulatory Surgery Centers (ASCs)
8.3.1. Overview
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
8.4. Home Care Settings
8.4.1. Overview
8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
8.5. Others
8.5.1. Overview
8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9. DRUG DEVICE COMBINATION MARKET– BY GEOGRAPHY
9.1. Introduction
9.1.1. Segment Share Analysis, By Geography, 2020 & 2027 (%)
9.2. North America
9.2.1. Overview
9.2.2. Key Manufacturers in North America
9.2.3. North America Market Size and Forecast, By Country, 2016 - 2027 (US$ Billion)
9.2.4. North America Market Size and Forecast, By Product, 2016 - 2027 (US$ Billion)
9.2.5. North America Market Size and Forecast, By End-User, 2016 - 2027 (US Billion)
9.2.6. North America Market Size and Forecast, By Vertical, 2016 - 2027 (US Billion)
9.2.7. U.S.
9.2.7.1. Overview
9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.2.7.3. U.S. Market Size and Forecast, By Product, 2016 - 2027 (US$ Billion)
9.2.7.4. U.S. Market Size and Forecast, By End-User, 2016 - 2027 (US Billion)
9.2.8. Canada
9.2.8.1. Overview
9.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.2.8.3. Canada Market Size and Forecast, By Product, 2016 - 2027 (US$ Billion)
9.2.8.4. Canada Market Size and Forecast, By End-User, 2016 - 2027 (US Billion)
9.3. Europe
9.3.1. Overview
9.3.2. Key Manufacturers in Europe
9.3.3. Europe Market Size and Forecast, By Country, 2016 - 2027 (US$ Billion)
9.3.4. Europe Market Size and Forecast, By Product, 2016 - 2027 (US$ Billion)
9.3.5. Europe Market Size and Forecast, By End-User, 2016 - 2027 (US Billion)
9.3.6. Germany
9.3.6.1. Overview
9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.3.6.3. Germany Market Size and Forecast, By Product, 2016 - 2027 (US$ Billion)
9.3.6.4. Germany Market Size and Forecast, By End-User, 2016 - 2027 (US Billion)
9.3.7. Italy
9.3.7.1. Overview
9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.3.7.3. Italy Market Size and Forecast, By Product, 2016 - 2027 (US$ Billion)
9.3.7.4. Italy Market Size and Forecast, By End-User, 2016 - 2027 (US Billion)
9.3.8. United Kingdom
9.3.8.1. Overview
9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.3.8.3. United Kingdom Market Size and Forecast, By Product, 2016 - 2027 (US$ Billion)
9.3.8.4. United Kingdom Market Size and Forecast, By End-User, 2016 - 2027 (US Billion)
9.3.9. France
9.3.9.1. Overview
9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.3.9.3. France Market Size and Forecast, By Product, 2016 - 2027 (US$ Billion)
9.3.9.4. France Market Size and Forecast, By End-User, 2016 - 2027 (US Billion)
9.3.10. Rest of Europe
9.3.10.1. Overview
9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.3.10.3. Rest of Europe Market Size and Forecast, By Product, 2016 - 2027 (US$ Billion)
9.3.10.4. Rest of Europe Market Size and Forecast, By End-User, 2016 - 2027 (US Billion)
9.4. Asia Pacific
9.4.1. Overview
9.4.2. Key Manufacturers in Asia Pacific
9.4.3. Asia Pacific Market Size and Forecast, By Country, 2016 - 2027 (US$ Billion)
9.4.4. Asia Pacific Market Size and Forecast, By Product, 2016 - 2027 (US$ Billion)
9.4.5. Asia Pacific Market Size and Forecast, By End-User, 2016 - 2027 (US Billion)
9.4.6. India
9.4.6.1. Overview
9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.4.6.3. India Market Size and Forecast, By Product, 2016 - 2027 (US$ Billion)
9.4.6.4. India Market Size and Forecast, By End-User, 2016 - 2027 (US Billion)
9.4.7. China
9.4.7.1. Overview
9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.4.7.3. China Market Size and Forecast, By Product, 2016 - 2027 (US$ Billion)
9.4.7.4. China Market Size and Forecast, By End-User, 2016 - 2027 (US Billion)
9.4.8. Japan
9.4.8.1. Overview
9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.4.8.3. Japan Market Size and Forecast, By Product, 2016 - 2027 (US$ Billion)
9.4.8.4. Japan Market Size and Forecast, By End-User, 2016 - 2027 (US Billion)
9.4.9. Rest of APAC
9.4.9.1. Overview
9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.4.9.3. Rest of APAC Market Size and Forecast, By Product, 2016 - 2027 (US$ Billion)
9.4.9.4. Rest of APAC Market Size and Forecast, By End-User, 2016 - 2027 (US Billion)
9.5. Latin America
9.5.1. Overview
9.5.2. Key Manufacturers in Latin America
9.5.3. Latin America Market Size and Forecast, By Country, 2016 - 2027 (US$ Billion)
9.5.4. Latin America Market Size and Forecast, By Product, 2016 - 2027 (US$ Billion)
9.5.5. Latin America Market Size and Forecast, By End-User, 2016 - 2027 (US Billion)
9.5.6. Brazil
9.5.6.1. Overview
9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.5.6.3. Brazil Market Size and Forecast, By Product, 2016 - 2027 (US$ Billion)
9.5.6.4. Brazil Market Size and Forecast, By End-User, 2016 - 2027 (US Billion)
9.5.7. Mexico
9.5.7.1. Overview
9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.5.7.3. Mexico Market Size and Forecast, By Product, 2016 - 2027 (US$ Billion)
9.5.7.4. Mexico Market Size and Forecast, By End-User, 2016 - 2027 (US Billion)
9.5.8. Argentina
9.5.8.1. Overview
9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.5.8.3. Argentina Market Size and Forecast, By Product, 2016 - 2027 (US$ Billion)
9.5.8.4. Argentina Market Size and Forecast, By End-User, 2016 - 2027 (US Billion)
9.5.9. Rest of Europe
9.5.9.1. Overview
9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.5.9.3. Rest of LATAM Market Size and Forecast, By Product, 2016 - 2027 (US$ Billion)
9.5.9.4. Rest of LATAM Market Size and Forecast, By End-User, 2016 - 2027 (US Billion)
9.6. Middle East and Africa
9.6.1. Overview
9.6.2. Key Manufacturers in Middle East and Africa
9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2016 - 2027 (US$ Billion)
9.6.4. Middle East and Africa Market Size and Forecast, By Product, 2016 - 2027 (US$ Billion)
9.6.5. Middle East and Africa Market Size and Forecast, By End-User, 2016 - 2027 (US$ Billion)
9.6.6. Saudi Arabia
9.6.6.1. Overview
9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.6.6.3. Saudi Arabia Market Size and Forecast, By Product, 2016 - 2027 (US$ Billion)
9.6.6.4. Saudi Arabia Market Size and Forecast, By End-User, 2016 - 2027 (US$ Billion)
9.6.7. United Arab Emirates
9.6.7.1. Overview
9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.6.7.3. United Arab Emirates Market Size and Forecast, By Product, 2016 - 2027 (US$ Billion)
9.6.7.4. United Arab Emirates Market Size and Forecast, By End-User, 2016 - 2027 (US$ Billion)
9.6.8. Rest of MEA
9.6.8.1. Overview
9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Billion)
9.6.8.3. Rest of MEA Market Size and Forecast, By Product, 2016 - 2027 (US$ Billion)
9.6.8.4. Rest of MEA Market Size and Forecast, By End-User, 2016 - 2027 (US$ Billion)
10. KEY VENDOR ANALYSIS
10.1. Competitive Dashboard
10.2. Company Profiles
10.2.1. Abbott Laboratories
10.2.1.1. Company Snapshot
10.2.1.2. Financial Performance
10.2.1.3. Product Benchmarking
10.2.1.4. Strategic Initiatives
10.2.2. Allergan Plc.
10.2.3. Boston Scientific Corporation
10.2.4. C.R. Bard Inc.
10.2.5. Medtronic
10.2.6. Mylan N.V
10.2.7. Novartis AG
10.2.8. St Jude Medical Inc.
10.2.9. Stryker Corporation
10.2.10. Teleflex Incorporated
10.2.11. Terumo Corporation
10.2.12. W.L. Core & Associates Inc.
10.2.13. Others
11. 360 DEGREE ANALYST VIEW
12. APPENDIX
12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us

Choose License Type
assit assit

Tailor made solution just for you

80% of our clients seek made-to-order reports. how do you want us to tailor yours?
📧 Talk to Analyst

We have 24/7 dedicated support team.

Get in Touch

© 2023. All rights reserved: AnalystView Market Insights